Why the study?
Does quetiapine cause myocarditis presenting as acute STEMI in a patient taking methylphenidate?
Does quetiapine cause myocarditis presenting as acute STEMI in a patient taking methylphenidate?
Quetiapine can induce myocarditis that mimics acute STEMI, highlighting the need to consider drug-induced etiologies in young patients presenting with acute coronary syndrome symptoms.
Answers are grounded in this paper and cite their sources.
Consider quetiapine-induced myocarditis in young patients with STEMI-like presentation; single case leaves open causality with methylphenidate.
An 18-year-old man diagnosed with attention-deficit hyperactivity disorder was recently started on quetiapine in addition to regular methylphenidate, which he had been taking for a number of years. He presented with chest pain and inferolateral ST elevation, and underwent urgent coronary angiography, which showed normal coronary arteries. The initial troponin level was raised and an inpatient echocardiogram showed mild left ventricular systolic dysfunction with no evidence of regional wall motion abnormality. Cardiac MRI showed subepicardial late gadolinium enhancement, which was suggestive of myocarditis. Quetiapine and methylphenidate were discontinued and the patient was discharged home after 1 week. He was followed up within 8 weeks with complete recovery and no symptoms.
No takes yet. Share an insight, caveat, or question.
Wassef et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: